Slingshot members are tracking this corporate initiative:
Cardiome and Allergan Announce XYDALBA (Dalbavancin) Licensing Agreement in International Markets
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: May 05, 2016 Projected Implementation: Q2, 2016 Relevance Tracked Until: Q4, 2016
Don’t see a project related to the strategic initiative you care about?
Related Keywords Xydalba, Dalbavancin, Licensing Agreement